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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERExpert Consensus Statement: Renal Denervation for Resistant Hypertension 2031
Markus P. Schlaich, Roland E. Schmieder, George Bakris, Peter J. Blankestijn, Michael Böhm,
Vito M. Campese, Darrel P. Francis, Guido Grassi, Dagmara Hering, Richard Katholi, Sverre Kjeldsen,
Henry Krum, Felix Mahfoud, Giuseppe Mancia, Franz H. Messerli, Krzysztof Narkiewicz,
Gianfranco Parati, Krishna J. Rocha-Singh, Luis M. Ruilope, Lars C. Rump, Domenic A. Sica,
Paul A. Sobotka, Costas Tsiouﬁs, Oliver Vonend, Michael A. Weber, Bryan Williams, Thomas Zeller,
Murray D. Esler
Catheter-based radiofrequency ablation technology to disrupt both efferent and afferent renal
nerves has recently been shown to signiﬁcantly reduce systolic and diastolic blood pressure.
This expert consensus statement reviews the clinical trial data available thus far and provides
recommendations for appropriate use of this emerging technology.SPECIAL ARTICLE CLASSIFICATION OF CARDIOMYOPATHYMOGE(S) Classiﬁcation 2046
Eloisa Arbustini, Navneet Narula, G. WilliamDec, K. Srinath Reddy, Barry Greenberg, Sudhir Kushwaha,
ThomasMarwick, Sean Pinney, Riccardo Bellazzi, Valentina Favalli, Christopher Kramer, Robert Roberts,
William A. Zoghbi, Robert Bonow, Luigi Tavazzi, Valentin Fuster, Jagat Narula
This article describes a proposed a systematic nomenclature for cardiomyopathies. The
proposed classiﬁcation is a descriptive presentation of the cardiomyopathic process, which is
ﬂexible, modiﬁable, and expandable. This nosology is inspired from the TNM staging of
tumors. The MOGE(S) Nomenclature System addresses 5 simple attributes of a
cardiomyopathic disorder including morpho-functional characteristic (M), organ
involvement (O), genetic or familial inheritance pattern (G), and an explicit etiological
annotation (E) with details of genetic defect or underlying disease/cause; information about
the functional status (S) using the stage and functional class can also be added. It is expected
that this description will be improved, revised, modiﬁed, and made more comprehensive and
user friendly over time. This system is designed to allow better understanding of the disease,
easier communication among physicians, and facilitate multicenter/multinational registries.
Commentary: Perry M. Elliott, p. 2073(continued on page A-21)
DECEMBER 3, 2013 (continued) A-21CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGYZotarolimus- Versus Everolimus-Eluting Stents for uLMCA 2075
Julinda Mehilli, Gert Richardt, Marco Valgimigli, Stefanie Schulz, Ambika Singh,
Mohamed Abdel-Wahab, Klaus Tiroch, Jürgen Pache, Jörg Hausleiter, Robert A. Byrne, Ilka Ott,
Tareq Ibrahim, Massimiliano Fusaro, Melchior Seyfarth, Karl-Ludwig Laugwitz, Steffen Massberg,
Adnan Kastrati, for the ISAR-LEFT-MAIN 2 Study Investigators
Mehilli and colleagues performed a randomized trial to compare the safety and efﬁcacy of
zotarolimus- and everolimus-eluting stents for the treatment of unprotected left main
coronary artery (uLMCA)disease.Therewasnodifference at 1 year in theprimary endpoint,which
was the combined incidence of death, myocardial infarction, and target lesion revascularization.
There was no difference in all-cause mortality at 1 year. Angiographic restenosis was not
signiﬁcantly different. Within the statistical limitations of this study of nearly 700 subjects,
zotarolimus- and everolimus-eluting stents provide comparable clinical and angiographic
outcomes for percutaneous coronary intervention of uLMCA.INTERVENTIONAL CARDIOLOGYWorse Outcomes in Patients Who Do Not Receive Aspirin Before PCI 2083
Mohamad Kenaan, Milan Seth, Herbert D. Aronow, David Wohns, David Share, Hitinder S. Gurm,
for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
Kenaan and colleagues examined the incidence and outcomes of percutaneous coronary
intervention (PCI) in patients who had not received pre-procedural aspirin. Using data from
44 hospitals in Michigan, 7.1% of the 65,000 subjects who underwent PCI did not receive
aspirin within 24 h prior to undergoing PCI. Aspirin nonreceivers were more likely to have
had prior gastrointestinal bleeding or to present with cardiogenic shock or cardiac arrest. In
the propensity-matched analysis, absence of aspirin prior to PCI was associated with a higher
rate of death (odds ratio [OR]: 1.89) and stroke (OR: 4.24) with no difference in need for
transfusions. These results show that a signiﬁcant number of patients do not receive aspirin
prior to undergoing PCI, which may increase the risk of death following the procedure.(continued on page A-26)
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Gianluigi Savarese, Antonio M. Gotto, Jr, Stefania Paolillo, Carmen D’Amore, Teresa Losco,
Francesca Musella, Oriana Scala, Caterina Marciano, Donatella Ruggiero, Fabio Marsico,
Giuseppe De Luca, Bruno Trimarco, Pasquale Perrone-Filardi
Savarese and colleagues performed a meta-analysis to determine whether statins reduce
all-cause mortality and cardiovascular (CV) events in elderly people without established CV
disease. Eight trials enrolling 24,674 subjects age >65 years (mean age 73 years; mean
follow-up 3.5 years) were included in the analyses. Compared with placebo, statins
signiﬁcantly reduced the risk of myocardial infarction (MI) by 39% and the risk of stroke by
24%. In contrast, the risk of all-cause death (risk ratio [RR]: 0.94; p ¼ 0.21) and of CV death
(RR: 0.91; p ¼ 0.493) were not signiﬁcantly reduced. These results show that statins can
signiﬁcantly reduce the risk of MI and stroke in elderly primary prevention subjects.
Editorial Comment: David D. Waters, p. 2100HEART RHYTHM DISORDERS: SUDDEN DEATHCardiac Arrest at Exercise Facilities 2102
Richard L. Page, Soﬁa Husain, Lindsay Y. White, Thomas D. Rea, Carol Fahrenbruch, Lihua Yin,
Peter J. Kudenchuk, Leonard A. Cobb, Mickey S. Eisenberg
Page and colleagues examined every public indoor sudden cardiac arrest in the Seattle area
from 1996 to 2008 and categorized each event as occurring at a traditional exercise center, an
alternative exercise site, or a public indoor location not used for exercise. Of 849 cardiac
arrests, 52 occurred at traditional exercise sites, 84 at alternative exercise sites, and 713 at sites
not associated with exercise. The site incident rates were higher at indoor tennis facilities,
indoor ice arenas, and bowling alleys than at traditional ﬁtness centers. Survival to hospital
discharge was greater for arrests that occurred at exercise sites (56% at traditional and 45% at
alternative) than at other public indoor locations (34%). These ﬁndings will be useful for
optimizing the deployment of automated external deﬁbrillators and other community
resources to improve survival rates of sudden cardiac death.
Editorial Comment: Sarah R. Gutbrod, Igor R. Eﬁmov, p. 2110(continued on page A-28)
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Ayman A. Hussein, John S. Gottdiener, Traci M. Bartz, Nona Sotoodehnia, Christopher deFilippi,
Timm Dickfeld, Rajat Deo, David Siscovick, Phyllis K. Stein, Donald Lloyd-Jones
Hussein and colleagues investigated the association between biomarkers of cardiomyocyte
injury in ambulatory subjects and sudden cardiac death (SCD). Levels of cardiac troponin T
were measured by a highly-sensitive cardiac troponin T (hsTnT) assay in 4,431 ambulatory
participants in a longitudinal, community-based, prospective cohort study. Over a median
follow-up of 13.1 years, baseline levels of hsTnT were signiﬁcantly and independently
associated with SCD. The hsTnT level was also predictive of incident heart failure and
myocardial infarction. These ﬁndings suggest an association between chronic cardiomyocyte
injury and SCD risk.
Editorial Comment: Oussama Wazni, Bryan Baranowski, p. 2121HYPERTENSIONBaroreﬂex Sensitivity and Renal Denervation 2124
Christine S. Zuern, Christian Eick, Konstantinos D. Rizas, Sarah Bauer, Harald Langer,
Meinrad Gawaz, Axel Bauer
Zuern and colleagues evaluated cardiac baroreﬂex sensitivity (BRS) as a predictor of response
to catheter-based renal sympathetic denervation (RDN). Prior to RDN, 50 subjects
underwent a 30-min recording of arterial blood pressure (BP) and high-resolution
electrocardiogram. Cardiac BRS was assessed by phase-rectiﬁed signal averaging (BRSPRSA).
Response toRDNwas deﬁned as a reduction ofmean systolic BP on ambulatory BPmonitoring
of 10 mm Hg or more at 6 months. The BRSPRSA was signiﬁcantly lower in one-half of
subjects whowereRDN responders than in nonresponders.Onmultivariable logistic regression
analysis, reduced BRSPRSAwas the strongest predictor of response to RDN. BRS testingmay
help to identify patients likely to respond to RDN.
Editorial Comment: David E. Kandzari, Paul A. Sobotka, p. 2131(continued on page A-30)
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Javariah Siddiqui, Christian P. Brizard, John C. Galati, Ajay J. Iyengar, Darren Hutchinson,
Igor E. Konstantinov, Gavin R. Wheaton, James M. Ramsay, Yves d’Udekem
There is controversy regarding the best approach to treat neonatal congenital aortic valve
stenosis: should it be surgical or interventional catheterization? Siddiqui and colleagues
performed a retrospective review of data and follow-up of 123 consecutive neonates
(age<30 days) and infants (age 31 days to 1 year) undergoing intervention for congenital aortic
stenosis. There were no differences in early or late mortality. Freedom from re-intervention at
5 years was 27% after balloon valvuloplasty versus 65% after surgery. While nonrandomized,
these results suggest that surgical valvuloplasty safely provides more durable results for neonates
and infants with congenital aortic stenosis.
Editorial Comment: Carl L. Backer, p. 2141
